BACKGROUND: Tuberculosis (TB) is a common diagnosis in human immunodeficiency virus (HIV) infected patients on antiretroviral treatment (ART). OBJECTIVE: To describe TB-related practices in ART programmes in lower-income countries and identify risk factors for TB in the first year of ART. METHODS: Programme characteristics were assessed using standardised electronic questionnaire. Patient data from 2003 to 2008 were analysed and incidence rate ratios (IRRs) calculated using Poisson regression models. RESULTS: Fifteen ART programmes in 12 countries in Africa, South America and Asia were included. Chest X-ray, sputum microscopy and culture were available free of charge in respectively 13 (86.7%), 14 (93.3%) and eight (53.3%) programmes. Eight sites (53.3%) used directly observed treatment and five (33.3%) routinely administered isoniazid preventive treatment (IPT). A total of 19 413 patients aged ≥ 16 years contributed 13,227 person-years of follow-up; 1081 new TB events were diagnosed. Risk factors included CD4 cell count (>350 cells/μl vs. <25 cells/μl, adjusted IRR 0.46, 95%CI 0.33-0.64, P < 0.0001), sex (women vs. men, adjusted IRR 0.77, 95%CI 0.68-0.88, P = 0.0001) and use of IPT (IRR 0.24, 95%CI 0.19-0.31, P < 0.0001). CONCLUSIONS: Diagnostic capacity and practices vary widely across ART programmes. IPT prevented TB, but was used in few programmes. More efforts are needed to reduce the burden of TB in HIV co-infected patients in lower income countries.
BACKGROUND:Tuberculosis (TB) is a common diagnosis in human immunodeficiency virus (HIV) infectedpatients on antiretroviral treatment (ART). OBJECTIVE: To describe TB-related practices in ART programmes in lower-income countries and identify risk factors for TB in the first year of ART. METHODS: Programme characteristics were assessed using standardised electronic questionnaire. Patient data from 2003 to 2008 were analysed and incidence rate ratios (IRRs) calculated using Poisson regression models. RESULTS: Fifteen ART programmes in 12 countries in Africa, South America and Asia were included. Chest X-ray, sputum microscopy and culture were available free of charge in respectively 13 (86.7%), 14 (93.3%) and eight (53.3%) programmes. Eight sites (53.3%) used directly observed treatment and five (33.3%) routinely administered isoniazid preventive treatment (IPT). A total of 19 413 patients aged ≥ 16 years contributed 13,227 person-years of follow-up; 1081 new TB events were diagnosed. Risk factors included CD4 cell count (>350 cells/μl vs. <25 cells/μl, adjusted IRR 0.46, 95%CI 0.33-0.64, P < 0.0001), sex (women vs. men, adjusted IRR 0.77, 95%CI 0.68-0.88, P = 0.0001) and use of IPT (IRR 0.24, 95%CI 0.19-0.31, P < 0.0001). CONCLUSIONS: Diagnostic capacity and practices vary widely across ART programmes. IPT prevented TB, but was used in few programmes. More efforts are needed to reduce the burden of TB in HIV co-infectedpatients in lower income countries.
Authors: Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: François Dabis; Eric Balestre; Paula Braitstein; Paolo Miotti; W G Martin Brinkhof; Martin Schneider; Mauro Schechter; Christian Laurent; Andrew Boulle; Charles Kabugo; Gorana Capkun; Catherine Seyler; James McIntyre; Eduardo Sprinz; David Bangsberg; Stefan Van der Borght; Matthias Egger Journal: Int J Epidemiol Date: 2005-09-12 Impact factor: 7.196
Authors: Robert M Einterz; Sylvester Kimaiyo; Haroun N K Mengech; Barasa O Khwa-Otsyula; Fabian Esamai; Fran Quigley; Joseph J Mamlin Journal: Acad Med Date: 2007-08 Impact factor: 6.893
Authors: P A Selwyn; P Alcabes; D Hartel; D Buono; E E Schoenbaum; R S Klein; K Davenny; G H Friedland Journal: N Engl J Med Date: 1992-12-10 Impact factor: 91.245
Authors: Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye Journal: Arch Intern Med Date: 2003-05-12
Authors: Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger Journal: Lancet Date: 2006-03-11 Impact factor: 79.321
Authors: Matthew P Fox; Mhairi Maskew; A Patrick MacPhail; Lawrence Long; Alana T Brennan; Daniel Westreich; William B MacLeod; Pappie Majuba; Ian M Sanne Journal: Int J Epidemiol Date: 2012-03-20 Impact factor: 7.196
Authors: B Burmen; S Modi; J S Cavanaugh; H Muttai; K D McCarthy; H Alexander; K Cain Journal: Int J Tuberc Lung Dis Date: 2016-01 Impact factor: 2.373
Authors: M Ballif; V Nhandu; R Wood; J C Dusingize; E J Carter; C P Cortes; C C McGowan; L Diero; C Graber; L Renner; D Hawerlander; S Kiertiburanakul; Q T Du; T R Sterling; M Egger; L Fenner Journal: Int J Tuberc Lung Dis Date: 2014-11 Impact factor: 2.373
Authors: Marie Ballif; Lorna Renner; Jean Claude Dusingize; Valeriane Leroy; Samuel Ayaya; Kara Wools-Kaloustian; Claudia P Cortes; Catherine C McGowan; Claire Graber; Anna M Mandalakas; Lynne M Mofenson; Matthias Egger; Ketut Dewi Kumara Wati; Revathy Nallusamy; Gary Reubenson; Mary-Ann Davies; Lukas Fenner Journal: J Pediatric Infect Dis Soc Date: 2014-03-28 Impact factor: 3.164
Authors: Lukas Fenner; Stewart E Reid; Matthew P Fox; Daniela Garone; Maureen Wellington; Hans Prozesky; Marcel Zwahlen; Michael Schomaker; Gilles Wandeler; Nzali Kancheya; Andrew Boulle; Robin Wood; German Henostroza; Matthias Egger Journal: Trop Med Int Health Date: 2012-11-30 Impact factor: 2.622
Authors: Molebogeng X Rangaka; Robert J Wilkinson; Andrew Boulle; Judith R Glynn; Katherine Fielding; Gilles van Cutsem; Katalin A Wilkinson; Rene Goliath; Shaheed Mathee; Eric Goemaere; Gary Maartens Journal: Lancet Date: 2014-05-13 Impact factor: 79.321
Authors: Lukas Fenner; Sebastien Gagneux; Jean-Paul Janssens; Jan Fehr; Matthias Cavassini; Matthias Hoffmann; Enos Bernasconi; Jacques Schrenzel; Thomas Bodmer; Erik C Böttger; Peter Helbling; Matthias Egger Journal: PLoS One Date: 2012-03-30 Impact factor: 3.240
Authors: Amitabh B Suthar; Stephen D Lawn; Julia del Amo; Haileyesus Getahun; Christopher Dye; Delphine Sculier; Timothy R Sterling; Richard E Chaisson; Brian G Williams; Anthony D Harries; Reuben M Granich Journal: PLoS Med Date: 2012-07-24 Impact factor: 11.069